Radiopharmaceuticals/Nuclear Medicine Market Projected To Grow With Significant Cagr Over The Forecast Period

18/giu/2018 12:48:58 rashmii Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

 

Medicines/ Drugs having radioactivity which are used for treatment of an illness is called as radiopharmaceuticals or Nuclear medicine. They are basically used for diagnostic or therapeutic purposes. Radiopharmaceuticals/nuclear medicine market report includes new product introductions, regulatory policies and competition analysis with graphical representation in the competition to assess the market. Moreover, PBI analyzed radiopharmaceuticals market will grow due to newer and better investment opportunities for market unmet needs.

Free sample of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

The global radiopharmaceuticals/Nuclear Medicine Market is growing at a significant rate due to rising in the prevalence of various types of cancers and cardiovascular diseases. The growing prevalence of various cancers resulted in an increased use of radiopharmaceuticals in diagnosis and treatment of several cancers in developed economies.  Moreover, advances in technology such as introduction of PET radiotracers and targeted radio-immunotherapies expected to drive the overall market revenue growth. The development of effective radiopharmaceuticals for diagnosis and treatment expected to drive the market revenue growth.

 

Free TOC of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/#ulp-c654SbFYO64MsOhu

 

 

The advances in imaging devices with radio-activity are helping healthcare professionals in effective diagnosis. Moreover, globally radio-imaging diagnosis is considered as an effective alternative to the conventional diagnosis techniques such as X-rays which is expected to boost the market demand for diagnostic radiopharmaceuticals. In addition, increase in the healthcare expenditure, radiopharmaceuticals abundance, and non-invasiveness in the treatment and diagnostic procedure might bolster the nuclear medicine market. 

The global radiopharmaceuticals/ Nuclear Medicine market is divided into following categories-

1.      Product type

·         Diagnostic Radiopharmaceuticals (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals)

·         Therapeutic Radiopharmaceuticals (Beta Emitters, Alpha emitters, Brachytherapy, and Others)

2.     Application

·         Oncology

·         Neurological disorders

·         Cardiovascular diseases

·         Thyroid

·         Others

3.      Route of Administration

·         Oral

·         Inhalation

·         Parenteral

4.     End Users

 

Ask Analyst for Full Information about this report @

 https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/#ulp-14mlyhjMGhVjZqa3

 

 

Hospitals, Clinics, Diagnostic Centers, and Research Institutes.

The global market of radiopharmaceuticals/ Nuclear Medicine is divided into five major regions- North America, Latin America, the Middle East, Asia Pacific and Europe. North America market holds the higher revenue share in global radiopharmaceuticals/Nuclear Medicine Market and projected to remain same owing to rising FDA approvals and production of radiopharmaceuticals in this region. Asia Pacific radiopharmaceuticals (nuclear medicine) market projected to grow at significant rate in comparison with other regions owing to conducive business environment and rising PET installations in the region.

Some of the key players profiled in the global Radiopharmaceuticals/Nuclear Medicine Market include: Advanced Accelerator Applications S.A. (France), Bayer AG (Germany), Bracco Imaging S.p.A  (Italy), Cardinal Health, Inc. (U.S.), Eli Lilly and Co. (U.S.), GE Healthcare (U.S.), IBA Molecular Imaging (Belgium), Jubilant Life Sciences Ltd (India), Lantheus Medical Imaging, Inc. (U.S.), Mallinckrodt plc (Ireland), Navidea Biopharmaceutical (U.S.), Nordion, Inc. (Canada), and Siemens Healthineers (Germany) are few names.

Players in the radiopharmaceuticals/Nuclear Medicine Market are focusing on expanding product portfolio, acquisitions, mergers, partnerships and collaborations to garner larger market revenue share in global radiopharmaceuticals/Nuclear Medicine Market.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl